KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Global Medical REIT (GMRE) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Global Medical REIT (GMRE) over the last 10 years, with Q3 2025 value amounting to 10.61%.

  • Global Medical REIT's EBITDA Margin fell 14200.0% to 10.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.0%, marking a year-over-year decrease of 39200.0%. This contributed to the annual value of 11.08% for FY2024, which is 32600.0% down from last year.
  • Latest data reveals that Global Medical REIT reported EBITDA Margin of 10.61% as of Q3 2025, which was down 14200.0% from 9.27% recorded in Q2 2025.
  • Global Medical REIT's 5-year EBITDA Margin high stood at 33.47% for Q3 2021, and its period low was 5.37% during Q4 2024.
  • Over the past 5 years, Global Medical REIT's median EBITDA Margin value was 14.85% (recorded in 2025), while the average stood at 18.0%.
  • As far as peak fluctuations go, Global Medical REIT's EBITDA Margin surged by 583500bps in 2021, and later crashed by -148900bps in 2022.
  • Quarter analysis of 5 years shows Global Medical REIT's EBITDA Margin stood at 29.46% in 2021, then tumbled by -51bps to 14.57% in 2022, then grew by 15bps to 16.78% in 2023, then tumbled by -68bps to 5.37% in 2024, then soared by 98bps to 10.61% in 2025.
  • Its EBITDA Margin stands at 10.61% for Q3 2025, versus 9.27% for Q2 2025 and 14.85% for Q1 2025.